CADTH recommends the reimbursement of Descovy (emtricitabine with tenofovir alafenamide fumarate)

24 August 2016 - CADTH is in favour of the reimbursement of Gilead's new dual combination product for HIV-1 infection. ...

Read more →

CADTH recommends reimbursement of Truvada for PrEP

24 August 2016 - The recommendation comes with conditions. ...

Read more →

CADTH calls for patient input on submissions for 2 new medicines for use by patients with HIV infection

5 February 2016 - CADTH has received notice of pending submissions from Theratechnologies for Egrifta (tesamorelin acetate) for lipodystrophy in HIV-infected ...

Read more →

CADTH calls for patient input

27 August 2015 - CADTH has received notice of a pending submission from GIlead for elvitegravir with cobicistat and emtricitabine and ...

Read more →